{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:05:05Z","timestamp":1767920705527,"version":"3.49.0"},"reference-count":29,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2008,10,26]],"date-time":"2008-10-26T00:00:00Z","timestamp":1224979200000},"content-version":"vor","delay-in-days":55,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold>  <jats:italic>Strongyloides stercoralis <\/jats:italic>may cause a complicated infection in immunocompromised patients, which has a high case fatality rate. Death generally results from sepsis with enteric pathogens. Globally, infection with the human T\u2010cell lymphotropic virus type 1 (HTLV\u20101) is a major risk factor for this syndrome. Both <jats:italic>S.\u2003stercoralis <\/jats:italic>and HTLV\u20101 are endemic to Central Australia.<\/jats:p><jats:p><jats:bold>Aims:\u2002<\/jats:bold> The aim of the study was to determine whether complicated strongyloidiasis occurs in association with HTLV\u20101 infection in Central Australia.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> A retrospective audit of all cases of complicated strongyloidiasis presenting to Alice Springs Hospital between January 2000 and December 2006 was carried out. Diagnosis was defined as definite or probable according to whether diagnosis was made by faecal studies or serology respectively. The medical records, investigations and outcomes of patients who met predetermined criteria for a diagnosis of complicated strongyloidiasis were reviewed.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Eighteen indigenous patients met the criteria for complicated strongyloidiasis (definite 9, probable 9). Seven of 11 patients tested were HTLV\u20101 seropositive. At diagnosis, no treatment was documented for nine patients (definite 4, probable 5), three received a single dose of ivermectin and one a single dose of albendazole. Fifteen patients (83%) died because of sepsis (definite 7, probable 8). Pathogens isolated and their foci of infection included <jats:italic>Klebsiella pneumoniae <\/jats:italic>pneumonia (4), bloodstream infection with <jats:italic>Enterococcus <\/jats:italic>spp. (2), <jats:italic>K.\u2003pneumoniae <\/jats:italic>peritonitis (1) and streptococcal meningitis (1).<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Complicated strongyloidiasis occurs in association with HTLV\u20101 infection in central Australia. This finding has significant implications for the management of <jats:italic>S.\u2003stercoralis <\/jats:italic>in the region.<\/jats:p>","DOI":"10.1111\/j.1445-5994.2008.01775.x","type":"journal-article","created":{"date-parts":[[2010,9,3]],"date-time":"2010-09-03T22:27:07Z","timestamp":1283552827000},"page":"697-703","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["<i>Strongyloides stercoralis<\/i>: a cause of morbidity and mortality for indigenous people in Central Australia"],"prefix":"10.1111","volume":"38","author":[{"given":"L.","family":"Einsiedel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,26]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-308X(08)60036-6"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/3.3.397"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1993.tb121693.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.280.6214.598"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2006.01172.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2005.12.006"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1993.tb137741.x"},{"key":"e_1_2_6_9_2","first-page":"526","article-title":"Prevention of opportunistic infections in immunocompromised patients in the tropical top end of the Northern Territory","volume":"27","author":"Davis JS","year":"2003","journal-title":"Commun Dis Intell"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.5.755"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1993.tb137694.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70081-6"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91186-P"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1993.tb137700.x"},{"key":"e_1_2_6_15_2","article-title":"High incidence of HTLV\u20101 antibody in carriers of Strongyloides stercoralis","volume":"1","author":"Nakada K","year":"1984","journal-title":"Lancet"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2006.74.246"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1999.60.146"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0141-9838.2004.00726.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.1.208-217.2004"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2001.65.610"},{"key":"e_1_2_6_21_2","volume-title":"HTLV\u20101 Studies in the Northern Territory","author":"Bastian I","year":"1996"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1086\/322707"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1996.55.477"},{"key":"e_1_2_6_24_2","first-page":"442","article-title":"Prevalence of strongyloides in northern Thailand and treatment with ivermectin vs albendazole","volume":"36","author":"Nontasut P","year":"2005","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01733.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-004-0345-z"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(94)90129-5"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2002.66.749"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/506938"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-5-128"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1445-5994.2008.01775.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1445-5994.2008.01775.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:26:27Z","timestamp":1697329587000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1445-5994.2008.01775.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1445-5994.2008.01775.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1445-5994.2008.01775.x","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"2008-10-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}